• Browse by: category | company | brand | product type  
  • HOME
  • THE GUIDE
  • ISSUES
  • GET INFORMED
  • GET INVOLVED
  • SHOP
  • ABOUT
  • CONTACT US
  • All  |
  • Appliances  |
  • Baby  |
  • Clothing  |
  • Electronics  |
  • Food & Drink  |
  • Household  |
  • Office Supplies  |
  • Personal Care  |
  • Pet  |
  • Retail  |
  • Toys
  • |  Print Guide  |
  • App
  • Clothing  |
  • Electronics  |
  • Food & Drink  |
  • Household & Personal Care
  • Issues  |
  • New! Clothing  |
  • Why Shop Ethically?  |
  • 5 Principles  |
  • Companies to avoid  |
  • News  |
  • Sign Up for Updates
  • Go ethical at school, work, home  |
  • Campaign  |
  • Spread the Word  |
  • Volunteer  |
  • Workshops  |
  • Movie Nights  |
  • Fundraising
  • All Products  |
  • Shop Ethical! app  |
  • Shop Ethical! book  |
  • Stockists  |
  • Other books  |
  • Fregie sacks  |
  • FREE STUFF!  |
  • DONATE
  • Introduction  |
  • About Us  |
  • Ratings & Assessment  |
  • Media Mentions  |
  • Testimonials  |
  • FAQ

Mylan Australia

OVERALL

Owned
NLD
Rating
Boycott

Pharmaceuticals

Established in 1982. Makers of generic medicines. Alphapharm is the largest supplier of medicines to the government subsidised Pharmaceutical Benefits Scheme. Operates a manufacturing plant in Queesland. Acquired by Mylan in 2007. Bought Aspen's portfolio of prescription and over-the-counter products in Australia for $188 million.

Company Ownership

Alphapharm Pty Ltd   AUS     website   email      
  Mylan NV   
   owns 100% of Alphapharm Pty Ltd  
NLD     website   email      

Pharmaceuticals

One the world's largest manufacturers of prescription generic drugs. Relocated its legal home from the USA to the Netherlands in 2015, presumably for tax reasons.

> About the Ratings

Company Assessment

PRAISE CRITICISM INFORMATION
Alphapharm Pty Ltd
Environment Australian Packaging Covenant signatory
Signatory to the Australian Packaging Covenant, a voluntary agreement to encourage waste minimisation.
[Source 2017][More on Packaging]
Business Ethics No tax paid in 2016/7
According to data released by the Australian Tax Office in Dec 2018, this company was one of 2,159 local and foreign-based companies that paid no tax in Australia in 2016-17. Please note however that companies pay income tax on profits, not revenue (total income). While some companies use tax havens and loopholes to avoid paying their fair share of tax in Australia, other companies that paid no tax have perfectly legitimate reasons.
[Source 2018][More on Finance]
Mylan NV
Business Ethics 20.2% in Newsweek Green Rankings 2016
This company received a score of 20.2/100 in the Newsweek Green Rankings 2016, which ranks the world's largest publicly traded companies on eight indicators covering energy, greenhouse gases, water, waste, fines and penalties, linking executive pay to sustainability targets, board-level committee oversight of environmental issues and third-party audits. Ranking methodology by Corporate Knights and HIP Investor.
[Source 2016][More on Sustainability Reporting]
Business Ethics Epipen Lawsuits
In August 2017, Mylan agreed to a $465 million settlement in a whistleblower lawsuit. The U.S. Justice Department and several states claimed the company overcharged Medicaid for EpiPens. As part of the settlement, Mylan did not have to admit any wrongdoing. The settlement came as Mylan faced growing complaints about skyrocketing price hikes for EpiPens. Between 2007 and 2016, Mylan increased the price of a two-pack of EpiPens from less than $100 to more than $600.
[Source 2017][More on Governance]
Business Ethics 39/100 SAM Rank
This company received a SAM Rank of 39/100 in the Pharmaceuticals category of the 2018 SAM Corporate Sustainability Assessment. The index is based on an analysis of corporate economic, environmental and social performance, assessing issues such as corporate governance, risk management, environmental reporting, climate strategy, human rights and labour practices.
[Source 2018][More on Sustainability Reporting]
Business Ethics Epipen price increase
Mylan, the makers of the EpiPen, an injectable device that is filled with medicine and can stop a life-threatening allergic reaction with immediate effect, have increased the price of the device from $100 in 2008 to above $500 in 2016, making it a hike of over 400 per cent. Epipens only cost a few dollars to make and the price-hike has caused a public outcry.
[Source 2016][More on Governance]
Social Modern Slavery statement
California, the UK and Australia have all enacted legislation requiring companies operating within their borders to disclose their efforts to eradicate modern slavery from their operations and supply chains. Follow the link to see this company's disclosure statement.
[Source 2016][More on Human Rights]
Information OpenSecrets.org profile
OpenSecrets.org tracks the influence of money on U.S. politics, and how that money affects policy and citizens' lives. Follow link to see this company's record of political donations, lobbying, outside spending and more.
[Source 2014]

> About the Icons

Company Details

Company Structure Wholly-owned subsidiary
# Employees 640 in 2017
Aus Manufacturing Yes

Contact Details

Address Level 1, 30 The Bond, 30-34 Hickson Rd, Millers Point, NSW, 2000, Australia
Phone 02 9298 3999
Fax 02 9566 4686
Email alphapharmss@alphapharm.com.au
Website www.mylan.com.au

Products / Brands

Mylan Australia
Dermeze Skin Care
Dermeze Bodywash/Shower Gel
Dymadon Pain Relief
Gastro-Stop Digestive Care
Irish Moss Cold & Flu
Stingose Antiseptic
Tums Digestive Care
Waxsol Eye & Ear Care
Zantac Digestive Care


  • Featured Pages

    • Clothing Guide – New!
    • Go ethical in your school
    • Go ethical in your church
    • Run a workshop or tour
    • All the issues
    • You can get involved!
  • Connect

    • Sign up for updates
    • Suggest a company/brand
    • Report an error
    • Newsletter
    • Like us on Facebook
    • Contact us
  • Legal

    • Copyright
    • Privacy
    • Disclaimer
    • Sitemap
  • ad